| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/16/2010 | WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 09/16/2010 | WO2010103094A1 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 09/16/2010 | WO2010103046A1 N-hydroxy c29-amide derivatives of oleandrane |
| 09/16/2010 | WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
| 09/16/2010 | WO2010102826A1 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
| 09/16/2010 | WO2010102825A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/16/2010 | WO2010021697A3 Antibodies to ccr2 |
| 09/16/2010 | US20100235929 Compositions and Methods for Producing Antibodies Having Human Idiotypes in Transgenic Birds |
| 09/16/2010 | US20100234578 Anti-cd40 monoclonal antibody |
| 09/16/2010 | US20100234473 Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines |
| 09/16/2010 | US20100234461 Compositions For Improved Oxidative Status In Companion |
| 09/16/2010 | US20100234448 In vivo production of small interfering rnas that mediate gene silencing |
| 09/16/2010 | US20100234440 Novel crystal of substituted phenylalkanoic acid ester and process for producing the same |
| 09/16/2010 | US20100234439 Therapeutic agents |
| 09/16/2010 | US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 09/16/2010 | US20100234406 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 09/16/2010 | US20100234404 P-38 Kinase Inhibitors |
| 09/16/2010 | US20100234397 Enzyme inhibitors |
| 09/16/2010 | US20100234396 Tetrhydropyridoindole Derivatives |
| 09/16/2010 | US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 09/16/2010 | US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 09/16/2010 | US20100234373 Bis-aryl amide compounds and methods of use |
| 09/16/2010 | US20100234370 Pharmaceutical compounds |
| 09/16/2010 | US20100234364 Ccr2 inhibitors and methods of use thereof |
| 09/16/2010 | US20100234356 Compounds useful as chemokine receptor antagonists |
| 09/16/2010 | US20100234346 Novel pyrimidine derivatives |
| 09/16/2010 | US20100234345 Novel compounds as cannabinoid receptor ligands |
| 09/16/2010 | US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators |
| 09/16/2010 | US20100234324 Quinazolinamide derivatives |
| 09/16/2010 | US20100234306 Use of a peptide as a therapeutic agent |
| 09/16/2010 | US20100234302 Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| 09/16/2010 | US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234272 Processes for Preparing a Polypeptide |
| 09/16/2010 | US20100233810 In vivo production of small interfering rnas that mediate gene silencing |
| 09/16/2010 | US20100233785 Novel methods and interferon deficient substrates for the propagation of viruses |
| 09/16/2010 | US20100233294 Use of tellurium compounds for inhibition of interleukin-converting enzyme |
| 09/16/2010 | US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A |
| 09/16/2010 | US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF |
| 09/16/2010 | US20100233229 In-vivo indwelling device |
| 09/16/2010 | US20100233212 Methods and compositions using listeria for enhancing immunogenicity by prime boost |
| 09/16/2010 | US20100233211 Attenuated francisella and methods of use |
| 09/16/2010 | US20100233208 Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics |
| 09/16/2010 | US20100233207 C-glycolipids with enhanced th-1 profile |
| 09/16/2010 | US20100233200 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells |
| 09/16/2010 | US20100233199 Modulators of hypersensitivity reactions |
| 09/16/2010 | US20100233197 Method for generating tolerogenic dendritic cells employing decreased temperature |
| 09/16/2010 | US20100233196 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
| 09/16/2010 | US20100233192 Manufacturing Method of Activated Lymphocytes for Immunotherapy |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |
| 09/16/2010 | US20100233183 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233158 Induction of immune tolerance |
| 09/16/2010 | US20100233153 Novel gene disruptions, compositions and the methods relating thereto |
| 09/16/2010 | US20100233142 Stem Cells Derived from Uniparental Embryos and Methods of Use Thereof |
| 09/16/2010 | US20100233126 Polypeptide |
| 09/16/2010 | US20100233119 Suppression of immune response to factor viii in hemophilia a patients |
| 09/16/2010 | US20100233118 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis |
| 09/16/2010 | US20100233117 Adjuvant combination formulations |
| 09/16/2010 | US20100233087 Cyp1b1 nucleic acids and methods of use |
| 09/16/2010 | US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 09/16/2010 | CA2755117A1 Substituted fused pyrimidine compounds |
| 09/16/2010 | CA2755061A1 Pyrimidine derivatives as mtor inhibitors |
| 09/16/2010 | CA2755047A1 Treatment methods for autoimmune disorders |
| 09/16/2010 | CA2754961A1 Treatment and diagnostic methods for hypersensitive disorders |
| 09/16/2010 | CA2754890A1 Novel bicyclic heterocycles |
| 09/16/2010 | CA2754804A1 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
| 09/16/2010 | CA2754801A1 Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor |
| 09/16/2010 | CA2754785A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/16/2010 | CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 09/16/2010 | CA2754603A1 Non-integrating retroviral vector vaccines |
| 09/16/2010 | CA2754592A1 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions |
| 09/16/2010 | CA2754109A1 Infectious disease cellular immunotherapy |
| 09/15/2010 | EP2228448A1 MU-1 member of the cytokine receptor family |
| 09/15/2010 | EP2228447A2 Cloning and characterizing of genes associated with long-term memory |
| 09/15/2010 | EP2228435A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 09/15/2010 | EP2228434A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228380A1 Novel triterpene derivatives |
| 09/15/2010 | EP2228369A1 Pyrazole derivatives as protein kinase modulators |
| 09/15/2010 | EP2228367A1 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| 09/15/2010 | EP2228067A1 Probiotic compound and use of same |
| 09/15/2010 | EP2228065A2 Heterocyclo inhibitors of potassium channel function |
| 09/15/2010 | EP2227489A2 Method for the detection of dead and dying cells |
| 09/15/2010 | EP2227459A2 Phenyl-oxetanyl-derivatives |
| 09/15/2010 | EP2227255A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 09/15/2010 | EP2227244A1 Cgrp as a therapeutic agent |
| 09/15/2010 | EP2227232A1 Methods for inhibiting t helper cell differentiation |
| 09/15/2010 | EP1830857B1 Beclomethasone dipropionate and prednisone for reducing mortality associated with graft-versus-host disease |
| 09/15/2010 | EP1572976B1 Modulating immune responses |
| 09/15/2010 | EP1536839B1 Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus |
| 09/15/2010 | EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
| 09/15/2010 | EP1154793B1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
| 09/15/2010 | CN1951502B Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 09/15/2010 | CN101835892A CDCA1 peptide and pharmaceutical agent comprising the same |
| 09/15/2010 | CN101831480A Staphylococcal enterotoxin C3 preparation, formulation, dosage and application thereof |
| 09/15/2010 | CN101831435A Preparation and application of IL-15 isoform protein of mice |
| 09/15/2010 | CN101831369A Golden fungus gingko yellow wine, preparation method and efficacy thereof |
| 09/15/2010 | CN101831355A 肉豆蔻复方精油 Nutmeg oil compound |